ESLA
Estrella Immunopharma (ESLA)
$67
About Estrella Immunopharma (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.15
52 Week Low
$0.73
Market cap
61.6M
Dividend yield
0.00%
Volume
--
Avg. volume
154,947
P/E ratio
-4.41
Estrella Immunopharma News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.15
52 Week Low
$0.73
Market cap
61.6M
Dividend yield
0.00%
Volume
--
Avg. volume
154,947
P/E ratio
-4.41